Comox Valley Woman’s Life at Risk as Diabetes Medication Supply Ends

A woman from Comox Valley is facing a dire situation as she runs out of a critical medication required for her rare condition, diabetes insipidus. Katherine Shields relies on a nasal spray form of the drug desmopressin, which is now in short supply across Canada. Without this medication, Shields could face severe health consequences, including the risk of death within weeks.

Shields, who takes approximately 30 sprays daily, has been informed that her current supply will last until around March 13, 2024. The urgency of her situation has intensified as the pharmaceutical manufacturer, AA Pharma, temporarily halted production last year due to manufacturing issues. This disruption has resulted in a nationwide shortage, leaving Shields and a small number of other patients without a reliable source of their necessary medication.

Diabetes insipidus, often referred to as water diabetes, disrupts the body’s ability to retain water, leading to excessive urination and persistent thirst. According to the Mayo Clinic, the condition is characterized by a deficiency of the hormone arginine vasopressin. While there is no cure for diabetes insipidus, treatment can alleviate symptoms and reduce the risk of dehydration.

Shields expressed her distress during an interview, stating, “It’s very worrisome, especially since you have a timeline of when you’re going to die.” She described the potential consequences of not receiving her medication, including organ failure due to the inability to retain water in her body.

Her mother, Trish Shields, echoed her concerns, stating, “This is just one of her life-saving drugs that she has to have, and without it, it’s not going to be pretty.” The urgency of the situation is compounded by the fact that alternative forms of the drug, such as pills, are ineffective for her condition.

The situation has prompted Katherine to reach out to various pharmacies, including her local Costco, but none currently have the medication in stock. Her father managed to locate three bottles in Powell River, traveling there to retrieve them on Saturday. In her quest for help, Katherine is appealing to the public and other pharmacies across the country, asking anyone with extra supplies to come forward.

As of now, the timeline for the resumption of desmopressin production remains uncertain. Initially, AA Pharma indicated that the supply would be available by February 6, but that date has since been pushed back multiple times to late March, with pharmacies potentially receiving stock only by April 5, if there are no further delays.

Shields’s plight highlights the critical need for reliable access to essential medications, particularly for those with rare and challenging health conditions. The ongoing shortage underscores the vulnerabilities faced by patients dependent on specific treatments and the importance of timely communication from pharmaceutical companies regarding supply issues.

Individuals who may have access to desmopressin or can offer assistance are encouraged to reach out via [email protected]. The community’s support could be vital in helping Katherine Shields manage her health during this critical time.